Skip to main content

Cancer Moonshot Scholars program

NCI Cancer Moonshot Scholars

The Cancer Moonshot Scholars program is designed to advance cancer science while also diversifying the pool of researchers and the approaches to cancer research that NCI funds. The program seeks to diversify the NCI R01 portfolio by enhancing the number of applications submitted by Early Stage Investigators from diverse backgrounds, including those from groups identified as underrepresented (NOT-OD-20-031) in the biomedical, clinical, behavioral, and social sciences research workforce. In addition, the program seeks to increase the diversity of thought and approach to cancer research. Individuals from underrepresented groups are especially encouraged to work with their respective institutions to apply.

NCI has issued the funding opportunity announcement for the Cancer Moonshot Scholars program and is accepting applications until November 8, 2022.

This program is supported by the White House's Cancer Moonshot initiative and aligns with NCI’s Equity and Inclusion Program and NIH’s UNITE Initiative. The Center to Reduce Cancer Health Disparities (CRCHD) will lead the Cancer Moonshot Scholars program, with regular input from a trans-NCI steering committee. NCI divisions that have subject matter expertise will manage the individual grant awards.

NCI intends to fund 45 new R01s through the program over the next three years.

Funding Opportunity & CRCHD Contacts

Application Due Dates & Purpose

RFA-CA-22-050 (R01 Clinical Trial Optional)

Dr. LeeAnn Bailey
(240) 276-5337

Dr. Tiffany Wallace
(240) 276-5114

Due Dates: November 8, 2022, June 6, 2023, February 6, 2024

The Cancer Moonshot Scholars program solicits R01 grant applications that propose independent research projects within the scientific mission of the National Cancer Institute (NCI). The program seeks to diversify the NCI R01 portfolio by enhancing the number of applications submitted by Early Stage Investigators from diverse backgrounds, including those from groups identified as underrepresented (NOT-OD-20-031) in the biomedical, clinical, behavioral, and social sciences research workforce.

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Cancer Moonshot Scholars program was originally published by the National Cancer Institute.”